CY1124079T1 - Αποτελεσματικη επιλεκτικοτητα των ανασυνδυασμενων πρωτεϊνων - Google Patents
Αποτελεσματικη επιλεκτικοτητα των ανασυνδυασμενων πρωτεϊνωνInfo
- Publication number
- CY1124079T1 CY1124079T1 CY20211100104T CY211100104T CY1124079T1 CY 1124079 T1 CY1124079 T1 CY 1124079T1 CY 20211100104 T CY20211100104 T CY 20211100104T CY 211100104 T CY211100104 T CY 211100104T CY 1124079 T1 CY1124079 T1 CY 1124079T1
- Authority
- CY
- Cyprus
- Prior art keywords
- recombinant proteins
- expression
- mammalian
- well
- invention includes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/005—Glycopeptides, glycoproteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
- C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Η εφεύρεση παρέχει ένα νέο σύστημα έκφρασης, που περιλαμβάνει έναν επιλέξιμο δείκτη θηλαστικού που προάγει τις επιθυμητές, μετα-μεταφραστικές τροποποιήσεις των γλυκοπρωτεϊνών. Συγκεκριμένα, η εφεύρεση περιλαμβάνει μεθόδους και συνθέσεις για τη βέλτιστη έκφραση των ανασυνδυασμένων πρωτεϊνών σε κύτταρα θηλαστικών, χρησιμοποιώντας ένα σύστημα επιλογής δείκτη, που βασίζεται σε γονίδια GPT που προέρχονται από θηλαστικά. Η εφεύρεση περιλαμβάνει μεθόδους που διευκολύνουν την επιλεκτικότητα και τα αντίγραφα ενισχυμένης έκφρασης καθώς και την πρωτεϊνική απόδοση των ανασυνδυασμένων πρωτεϊνών σε κύτταρα θηλαστικών αλλά και μεθόδους που χρησιμοποιούν συστήματα έκφρασης GPT.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462039416P | 2014-08-19 | 2014-08-19 | |
PCT/US2015/045793 WO2016028838A1 (en) | 2014-08-19 | 2015-08-19 | Efficient selectivity of recombinant proteins |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1124079T1 true CY1124079T1 (el) | 2022-05-27 |
Family
ID=55347784
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20211100104T CY1124079T1 (el) | 2014-08-19 | 2021-02-08 | Αποτελεσματικη επιλεκτικοτητα των ανασυνδυασμενων πρωτεϊνων |
Country Status (27)
Country | Link |
---|---|
US (4) | US9732357B2 (el) |
EP (2) | EP3901274A1 (el) |
JP (3) | JP7115851B2 (el) |
KR (2) | KR102406976B1 (el) |
CN (2) | CN107075549B (el) |
AR (1) | AR102333A1 (el) |
AU (3) | AU2015305565B9 (el) |
BR (1) | BR112017003074A2 (el) |
CA (1) | CA2957036A1 (el) |
CY (1) | CY1124079T1 (el) |
DK (1) | DK3183359T3 (el) |
EA (1) | EA035340B1 (el) |
ES (1) | ES2849728T3 (el) |
HR (1) | HRP20210301T1 (el) |
HU (1) | HUE054069T2 (el) |
IL (3) | IL287020B (el) |
LT (1) | LT3183359T (el) |
MA (1) | MA40371B1 (el) |
MX (2) | MX2017002203A (el) |
MY (1) | MY191745A (el) |
PL (1) | PL3183359T3 (el) |
PT (1) | PT3183359T (el) |
RS (1) | RS61371B1 (el) |
SG (2) | SG10201707859RA (el) |
SI (1) | SI3183359T1 (el) |
TW (3) | TWI777374B (el) |
WO (1) | WO2016028838A1 (el) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR102333A1 (es) | 2014-08-19 | 2017-02-22 | Regeneron Pharma | Selectividad eficiente de proteínas recombinadas |
EP3749754A4 (en) * | 2018-02-08 | 2021-10-20 | Applied Stemcell, Inc. | PROCEDURE FOR SCREENING VARIANTS OF A TARGET |
WO2021079909A1 (ja) | 2019-10-23 | 2021-04-29 | キヤノン株式会社 | セラミックス物品の製造方法およびセラミックス物品 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4634665A (en) | 1980-02-25 | 1987-01-06 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
US4656134A (en) | 1982-01-11 | 1987-04-07 | Board Of Trustees Of Leland Stanford Jr. University | Gene amplification in eukaryotic cells |
US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
US6077835A (en) | 1994-03-23 | 2000-06-20 | Case Western Reserve University | Delivery of compacted nucleic acid to cells |
KR970029803A (ko) | 1995-11-03 | 1997-06-26 | 김광호 | 반도체 메모리장치의 프리차지 회로 |
US5972650A (en) | 1997-06-26 | 1999-10-26 | Brigham And Women's Hospital | Tetracycline repressor regulated mammalian cell transcription and viral replication switch |
US6281005B1 (en) | 1999-05-14 | 2001-08-28 | Copernicus Therapeutics, Inc. | Automated nucleic acid compaction device |
US6919183B2 (en) | 2001-01-16 | 2005-07-19 | Regeneron Pharmaceuticals, Inc. | Isolating cells expressing secreted proteins |
ATE496134T1 (de) | 2002-03-29 | 2011-02-15 | Xoma Technology Ltd | Multigene vectoren und methoden für eine erhöhte expression von rekombinanten polypeptiden |
US8673589B2 (en) | 2002-05-29 | 2014-03-18 | Regeneron Pharmaceuticals, Inc. | Inducible eukaryotic expression system |
US7384744B2 (en) * | 2002-11-29 | 2008-06-10 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | Expression vector, methods for the production of heterologous gene products and for the selection of recombinant cells producing high levels of such products |
JP2005027599A (ja) * | 2003-07-09 | 2005-02-03 | Nara Institute Of Science & Technology | 植物由来遺伝子を用いた遺伝子導入植物の選抜法 |
EP1586585A1 (de) * | 2004-04-14 | 2005-10-19 | F. Hoffmann-La Roche Ag | Expressionssystem zur Herstellung von IL-15/Fc-Fusionsproteinen und ihre Verwendung |
CA2671365C (en) | 2006-12-07 | 2020-07-21 | Dow Agrosciences Llc | Use of dsm-2 gene as a selectable marker for selecting herbicidal resistant plants |
PL2150617T3 (pl) | 2007-06-04 | 2015-04-30 | Regeneron Pharma | Wzmocniona ekspresja i regiony stabilności |
KR100927803B1 (ko) * | 2007-11-23 | 2009-11-23 | 한국생명공학연구원 | 식물 형질전환체를 선별하기 위한 마커로서 gpt 유전자 |
ME03057B (me) * | 2007-12-07 | 2019-01-20 | Zymogenetics Inc | Molekuli humanizovanih antitela specifični za il-31 |
WO2009131681A2 (en) * | 2008-04-22 | 2009-10-29 | Rutgers, The State University | Hcv e2 construct compositions and methods |
WO2010077297A1 (en) * | 2008-12-09 | 2010-07-08 | Halozyme, Inc. | Extended soluble ph20 polypeptides and uses thereof |
EP2674495A1 (en) | 2012-06-14 | 2013-12-18 | Sanofi | CHO expression system |
AR102333A1 (es) | 2014-08-19 | 2017-02-22 | Regeneron Pharma | Selectividad eficiente de proteínas recombinadas |
-
2015
- 2015-08-14 AR ARP150102631A patent/AR102333A1/es unknown
- 2015-08-17 TW TW110101888A patent/TWI777374B/zh active
- 2015-08-17 TW TW104126657A patent/TWI719945B/zh active
- 2015-08-17 TW TW111129504A patent/TWI832364B/zh active
- 2015-08-19 SI SI201531487T patent/SI3183359T1/sl unknown
- 2015-08-19 BR BR112017003074-8A patent/BR112017003074A2/pt active Search and Examination
- 2015-08-19 EA EA201790241A patent/EA035340B1/ru unknown
- 2015-08-19 MY MYPI2017700248A patent/MY191745A/en unknown
- 2015-08-19 WO PCT/US2015/045793 patent/WO2016028838A1/en active Application Filing
- 2015-08-19 ES ES15833421T patent/ES2849728T3/es active Active
- 2015-08-19 HU HUE15833421A patent/HUE054069T2/hu unknown
- 2015-08-19 EP EP20211902.0A patent/EP3901274A1/en active Pending
- 2015-08-19 IL IL287020A patent/IL287020B/en unknown
- 2015-08-19 KR KR1020177006620A patent/KR102406976B1/ko active IP Right Grant
- 2015-08-19 CA CA2957036A patent/CA2957036A1/en active Pending
- 2015-08-19 AU AU2015305565A patent/AU2015305565B9/en active Active
- 2015-08-19 JP JP2017509733A patent/JP7115851B2/ja active Active
- 2015-08-19 PT PT158334219T patent/PT3183359T/pt unknown
- 2015-08-19 KR KR1020227018877A patent/KR102556383B1/ko active IP Right Grant
- 2015-08-19 MA MA40371A patent/MA40371B1/fr unknown
- 2015-08-19 CN CN201580044100.7A patent/CN107075549B/zh active Active
- 2015-08-19 US US14/829,834 patent/US9732357B2/en active Active
- 2015-08-19 PL PL15833421T patent/PL3183359T3/pl unknown
- 2015-08-19 CN CN202110402963.4A patent/CN113293139A/zh active Pending
- 2015-08-19 EP EP15833421.9A patent/EP3183359B1/en active Active
- 2015-08-19 SG SG10201707859RA patent/SG10201707859RA/en unknown
- 2015-08-19 LT LTEP15833421.9T patent/LT3183359T/lt unknown
- 2015-08-19 DK DK15833421.9T patent/DK3183359T3/da active
- 2015-08-19 SG SG11201701121UA patent/SG11201701121UA/en unknown
- 2015-08-19 RS RS20210103A patent/RS61371B1/sr unknown
- 2015-08-19 MX MX2017002203A patent/MX2017002203A/es unknown
-
2017
- 2017-02-09 IL IL250531A patent/IL250531B/en unknown
- 2017-02-17 MX MX2021009154A patent/MX2021009154A/es unknown
- 2017-07-31 US US15/664,444 patent/US10457959B2/en active Active
-
2019
- 2019-09-10 US US16/566,253 patent/US11085053B2/en active Active
-
2020
- 2020-07-17 AU AU2020205336A patent/AU2020205336B2/en active Active
- 2020-08-05 JP JP2020132874A patent/JP7260510B2/ja active Active
-
2021
- 2021-02-08 CY CY20211100104T patent/CY1124079T1/el unknown
- 2021-02-23 HR HRP20210301TT patent/HRP20210301T1/hr unknown
- 2021-07-02 US US17/366,239 patent/US20210340564A1/en active Pending
-
2022
- 2022-08-04 IL IL295361A patent/IL295361B2/en unknown
-
2023
- 2023-02-10 AU AU2023200752A patent/AU2023200752B2/en active Active
- 2023-04-06 JP JP2023061971A patent/JP2023076667A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1125392T1 (el) | Συνθεσεις και μεθοδοι γλυζυλιωσης πρωτεϊνων | |
BR112019007288A2 (pt) | proteína heterodimérica biespecífica, composições de ácido nucleico e de vetor de expressão, vetor de expressão, célula hospedeira, e, métodos para produzir proteína heterodimérica biespecífica e para tratar câncer em um paciente | |
MX2017014908A (es) | Proteinas de union triespecificas y metodos de uso. | |
PH12018501280A1 (en) | Anti-myostatin antibodies, polypeptides containing variant fc regions, and methods of use | |
CR20170282A (es) | Nuevos péptidos y nueva combinación de péptidos para el uso en la inmunoterapia contra el carcinoma hepatocelular (chc) y otros tipos de cáncer | |
BR112017025564B8 (pt) | Anticorpos anti-ctla-4 e métodos de uso dos mesmos | |
CY1122803T1 (el) | Διαδικασιες γραμμης παραγωγης σπορων και χρησεις αυτων | |
PH12018500252A1 (en) | Factor ix fusion protiens and methods of making and using same | |
PH12017501115A1 (en) | Anti-myostatin antibodies, polypeptides containing variant fc regions, and method of use | |
CY1124079T1 (el) | Αποτελεσματικη επιλεκτικοτητα των ανασυνδυασμενων πρωτεϊνων | |
MX2019006043A (es) | Proteína de unión de antígeno prostático específico de membrana. | |
CY1124727T1 (el) | Πρωτεϊνες συντηξης tatk-cdkl5, συνθεσεις, φαρμακοτεχνικες μορφες και η χρηση αυτων | |
CY1122214T1 (el) | Αντισωματα ειδικα για ton fcrn | |
CY1120997T1 (el) | Πρωτεϊνες συντηξης uti | |
MX2015014424A (es) | Construcciones de proteinas mitocondriales y sus usos. | |
EA201791918A1 (ru) | Модификация белков клеток-хозяев | |
EA201691532A1 (ru) | Сверхэкспрессия регуляторов пути n-гликозилирования для модуляции гликозилирования рекомбинантных белков | |
MX2018003445A (es) | Expresion de proteinas que contienen fc. | |
AU2017305946A8 (en) | C1q and HMGB1 fusion proteins and uses thereof | |
EA201892085A1 (ru) | Новые белки, полученные из альфа-1-микроглобулина, и их применение | |
BR112016015958A2 (pt) | Drives de genes guiados pelo rna |